Kantele Anu M, Palkola Nina V, Arvilommi Heikki S, Kantele Jussi M
Department of Medicine, Division of Infectious Diseases, Helsinki University Central Hospital, Helsinki, Finland.
Clin Immunol. 2008 Sep;128(3):427-34. doi: 10.1016/j.clim.2008.05.003. Epub 2008 Jun 27.
In contrast to other mucosal sites, information on migration/homing of lymphocytes activated in the human urinary tract is lacking. The expression of lymphocyte homing receptors (HR) on pathogen-specific antibody-secreting cells (ASC) originating from the urinary tract (patients with pyelonephritis, PN) was compared to that on antigen-specific ASC originating from the intestine (patients with gastroenteritis) or from a parenteral site (tetanus toxoid-immunized volunteers). In the PN group, 61% of ASC expressed the gut HR, alpha(4)beta(7,) 52% the peripheral lymph node HR, L-selectin, and 13% the skin HR, CLA. This homing profile of urinary tract-originating lymphocytes was found to differ from both of the two major vaccination routes, intestinal (less gut-targeting) or parenteral (more gut-targeting, less targeting to parenteral sites). This information on targeting of the immune response may prove useful when developing vaccines against urinary tract infection (UTI).
与其他黏膜部位不同,目前缺乏关于在人类泌尿道中被激活的淋巴细胞迁移/归巢的信息。将源自泌尿道(肾盂肾炎患者,PN)的病原体特异性抗体分泌细胞(ASC)上淋巴细胞归巢受体(HR)的表达,与源自肠道(肠胃炎患者)或非肠道部位(破伤风类毒素免疫志愿者)的抗原特异性ASC上的表达进行了比较。在PN组中,61%的ASC表达肠道HR,α4β7,52%表达外周淋巴结HR,L-选择素,13%表达皮肤HR,CLA。发现源自泌尿道的淋巴细胞的这种归巢模式不同于两种主要的疫苗接种途径,即肠道途径(肠道靶向性较低)或非肠道途径(肠道靶向性较高,非肠道部位靶向性较低)。当开发针对尿路感染(UTI)的疫苗时,这种关于免疫反应靶向性的信息可能会被证明是有用的。